Prof. Ori Elkayam (Tel Aviv Medical Center, Tel Aviv, Israel) kindly took the time to speak with touchIMMUNOLOGY about the current EULAR recommendations for vaccination in patients with autoimmune inflammatory rheumatic disease.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
Prof. Eklaya’s talk entitled ‘Vaccines in Rheumatology: Quick EULAR Update’ was presented at the ACR Convergence, 5-9 November 2021.
Questions
- What have been the EULAR recommendations for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD)? (0:06)
- What other EULAR updates should we be aware of? (2:07)
- What are the recommendations in terms of SARV-CoV-2 vaccination in these patients? (2:53)
- What are the safety concerns of vaccinations for people with AIIR? (3:15)
Disclosures: Prof. Ori Elkayam has received grant/ honorary fees from Pfizer, Abbvie, Eli Lilly, Novartis and Boehringer Ingelheim.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Gina Furnival.
Filmed in coverage of virtual ACR Convergence 2021.
